ArticlePLoS pathogens2020

Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma.

Shanli Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.